C.R. Bard and Davol Inc. are facing a new product liability claim from a Missouri woman, alleging she needed to undergo revision surgery due to painful hernia mesh patch symptoms.

The woman filed the lawsuit alleging the pharmaceutical companies failed to warn her or her physician against painful hernia mesh patch symptoms, which ultimately worsened her medical condition.

Plaintiff Marianna C. filed this hernia mesh lawsuit after discovering the companies either knew or should have known about the potential hernia mesh patch symptoms associated with the ePTFE Bard Mesh product.

According to the hernia mesh lawsuit, Marianna had undergone surgery for a right inguinal hernia on Aug. 19, 2011. She chose the ePTFE Bard Mesh product in consultation with her physician, even though they both were allegedly unaware of the painful hernia mesh patch symptoms associated with the product.

Marianna reportedly had no initial adverse reactions to the ePTFE Bard Mesh product. Later, she visited her physician on Jan. 29, 2013 for painful hernia mesh patch symptoms. According to her physician, the ePTFE Bard Mesh product had “curled a little bit laterally but there is no recurrence. There is an area of inflammation in the subcutaneous tissue which corresponds to hernia of tenderness.”

Marianna says she returned for medical assistance on Feb. 14, 2013 suffering from painful hernia mesh patch symptoms. She underwent an injection of her right side to help soothe the pain.

Marianna eventually underwent revision surgery on June 6, 2014, in which the ePTFE Bard Mesh was explanted. When the hernia mesh was removed, Marianna’s doctor noted he “found a folded wad of mesh” and had diagnosed Marianna with meshoma. This condition is described as when the hernia mesh shifts from implant position, and folds in on itself while inside the patient.

According to the hernia mesh lawsuit, Marianna continues to experience painful hernia mesh patch symptoms and will most likely require additional surgeries to repair the damage. Marianna opted to file legal action against Bard and Davol after discovering the allegedly defective nature of the ePTFE Bard Mesh product.

Overview of Hernia Mesh Patch Symptoms

Surgical mesh has been used for hernia repair for over 50 years, and has helped millions of patients recover from this painful condition. However, the medical community has been concerned over potential hernia mesh complications for years, with recent litigation against Bard and other companies further highlighting these problems.

Numerous patients have reportedly developed adverse reactions to hernia mesh, causing instances of inflammation and infection. While hernia mesh is designed to trigger inflammation inside the body, in order for muscle to swell around the mesh in furthering the hernia recovery process, the inflammation is supposed to dissipate after a certain point.

When this does not happen, this often leads to infections and can cause a number of other adverse effects to the patients including:

• Adhesions
• Obstructions
• Swelling
• Mesh Migration
• Hernia Recurrence

These painful hernia mesh patch symptoms often create the need for revision surgery, which is considered riskier than the initial implant procedure. Even though these complications can be devastating to patients, Bard and Davol allegedly failed to warn Marianna against them.

Marianna states she would not have agreed to use the ePTFE Bard Mesh product if she had known of its allegedly defective nature.

This Hernia Mesh Lawsuit is Case No. 2:18-cv-04015-MDH, in the U.S. District Court for the Western District of Missouri.